Balyasny Asset Management LLC Fibrogen Inc Put Options Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$37.09 - $48.97 $741,800 - $979,400
-20,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$40.47 - $45.5 $809,400 - $910,000
20,000 New
20,000 $822,000
Q2 2019

Aug 14, 2019
SELL
$35.13 - $55.53 $4.43 Million - $7 Million
-126,000 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$42.83 - $59.91 $5.4 Million - $7.55 Million
126,000 New
126,000 $6.85 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email